356 related articles for article (PubMed ID: 12970270)
21. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
[TBL] [Abstract][Full Text] [Related]
22. Thyroid incidentalomas identified by 18F-FDG PET: sonographic correlation.
Kwak JY; Kim EK; Yun M; Cho A; Kim MJ; Son EJ; Oh KK
AJR Am J Roentgenol; 2008 Aug; 191(2):598-603. PubMed ID: 18647938
[TBL] [Abstract][Full Text] [Related]
23. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
Soelberg KK; Bonnema SJ; Brix TH; Hegedüs L
Thyroid; 2012 Sep; 22(9):918-25. PubMed ID: 22827552
[TBL] [Abstract][Full Text] [Related]
24. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.
Cohen MS; Arslan N; Dehdashti F; Doherty GM; Lairmore TC; Brunt LM; Moley JF
Surgery; 2001 Dec; 130(6):941-6. PubMed ID: 11742321
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas.
Bertagna F; Treglia G; Piccardo A; Giubbini R
J Clin Endocrinol Metab; 2012 Nov; 97(11):3866-75. PubMed ID: 22904176
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance and management of incidental focal FDG uptake in the thyroid gland on positron emission tomography/computed tomography (PET/CT) in patients with non-thyroidal malignancy.
Wong C; Lin M; Chicco A; Benson R
Acta Radiol; 2011 Oct; 52(8):899-904. PubMed ID: 21873505
[TBL] [Abstract][Full Text] [Related]
27. The significance and management of incidental [18F]fluorodeoxyglucose-positron-emission tomography uptake in the thyroid gland in patients with cancer.
Eloy JA; Brett EM; Fatterpekar GM; Kostakoglu L; Som PM; Desai SC; Genden EM
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1431-4. PubMed ID: 19342543
[TBL] [Abstract][Full Text] [Related]
28. Thyroid Incidentalomas Detected on
Chung SR; Choi YJ; Suh CH; Kim HJ; Lee JJ; Kim WG; Sung TY; Lee YM; Song DE; Lee JH; Baek JH
Thyroid; 2018 Jun; 28(6):762-768. PubMed ID: 29759033
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
Ho TY; Liou MJ; Lin KJ; Yen TC
Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
[TBL] [Abstract][Full Text] [Related]
30. The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas.
Hsiao YC; Wu PS; Chiu NT; Yao WJ; Lee BF; Peng SL
Clin Radiol; 2011 Dec; 66(12):1197-202. PubMed ID: 21907336
[TBL] [Abstract][Full Text] [Related]
31. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
[TBL] [Abstract][Full Text] [Related]
32. Positron emission tomography thyroid incidentaloma: Is it different in Indian subcontinent?
Vaish R; Venkatesh R; Chaukar DA; Deshmukh AD; Purandare NC; D'cruz AK
Indian J Cancer; 2016; 53(1):186-9. PubMed ID: 27146775
[TBL] [Abstract][Full Text] [Related]
33. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer - a large retrospective monocentric study.
Kim H; Kim SJ; Kim IJ; Kim K
Onkologie; 2013; 36(5):260-4. PubMed ID: 23689220
[TBL] [Abstract][Full Text] [Related]
34. Pathology results in [18F]fluorodeoxyglucose positron emission tomography of the thyroid gland.
Wolf G; Aigner RM; Schaffler G; Schwarz T; Krippl P
Nucl Med Commun; 2003 Dec; 24(12):1225-30. PubMed ID: 14627848
[TBL] [Abstract][Full Text] [Related]
35.
Pattison DA; Bozin M; Gorelik A; Hofman MS; Hicks RJ; Skandarajah A
J Nucl Med; 2018 May; 59(5):749-755. PubMed ID: 29025986
[No Abstract] [Full Text] [Related]
36. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies.
Czepczyński R; Stangierski A; Oleksa R; Janicka-Jedyńska M; Czarnywojtek A; Ruchała M; Sowiński J
Nucl Med Rev Cent East Eur; 2011; 14(2):68-72. PubMed ID: 22474717
[TBL] [Abstract][Full Text] [Related]
37. Thyroid cancer presenting as a PET incidentaloma in a patient with concomitant breast cancer metastases to the thyroid.
Leboeuf R; Bénard F; Langlois MF
Clin Nucl Med; 2006 Jul; 31(7):382-5. PubMed ID: 16785803
[TBL] [Abstract][Full Text] [Related]
38. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
[TBL] [Abstract][Full Text] [Related]
39. Focal Thyroid Incidentalomas on
de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
[TBL] [Abstract][Full Text] [Related]
40. Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma.
Van den Bruel A; Maes A; De Potter T; Mortelmans L; Drijkoningen M; Van Damme B; Delaere P; Bouillon R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1517-20. PubMed ID: 11932274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
